NIKKEI 225
38,837.46 -85.54 (-0.22%) HANG SENG
18,444.11 +41.11 (+0.22%) CRUDE OIL
72.95 -0.30 (-0.41%) GOLD FUTURES
2,347.70 +0.30 (+0.01%) DOW
38,711.29 +140.26 (+0.36%) Bitcoin GBP
55,225.26 +1,250.84 (+2.32%)
Vir Biotechnology, Inc. (VIR)
After hours:
| Previous close | 10.63 |
| Open | 10.64 |
| Bid | 10.55 x 600 |
| Ask | 10.59 x 100 |
| Day's range | 10.46 - 11.27 |
| 52-week range | 7.61 - 27.48 |
| Volume | |
| Avg. volume | 892,220 |
| Market cap | 1.44B |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.01 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.29 |
Business WireVir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
SAN FRANCISCO, May 29, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, at 11:00 a.m. PT / 2:00 p.m. ET at the Loews Miami Beach Hotel, Miami Beach, Florida.
Business WireVir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer
SAN FRANCISCO, May 29, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Mark D. Eisner, M.D., M.P.H. will join the company as Executive Vice President and Chief Medical Officer (CMO), effective June 03, 2024. Dr. Eisner will be a part of the company’s Executive Management Team and will report directly to Marianne De Backer, M.Sc., Ph.D., MBA, Vir’s Chief Executive Officer.
Business WireVir Biotechnology to Host 2024 Annual Meeting of Stockholders
SAN FRANCISCO, May 23, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2024 Annual Meeting of Stockholders on Wednesday, May 29, 2024, at 9:00 a.m. PT. The Annual Meeting will be held in virtual format only via live audio webcast.
